$COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Vikram Karnani
CEO
357
Employees
$34.22
Current Price
$1.43B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $681.00 | 20 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 4 | $628,579.76 | 17,347 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 4 | $628,579.76 | 17,347 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 8 | $3,364,225.30 | 87,523 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 18, 2026 | Freund John Gordon Director | Sale | 20 | $34.05 | $681.00 | View Details |
| May 15, 2026 | Freund John Gordon Director | Sale | 4,127 | $34.54 | $142,546.58 | View Details |
| May 13, 2026 | Lurker Nancy Director | Sale | 4,500 | $35.97 | $161,860.95 | View Details |
| May 11, 2026 | BOHLIN GAREN G Director | Sale | 8,700 | $37.18 | $323,491.23 | View Details |
| Mar 18, 2026 | Dieter David EVP & General Counsel | Sale | 13,976 | $34.92 | $488,099.22 | View Details |
| Mar 9, 2026 | Dieter David EVP & General Counsel | Sale | 6,224 | $36.65 | $228,109.60 | View Details |
| Mar 3, 2026 | Dreyer Scott EVP & Chief Commercial Officer | Sale | 46,417 | $40.36 | $1,873,557.22 | View Details |
| Mar 3, 2026 | Dreyer Scott EVP & Chief Commercial Officer | Sale | 3,559 | $40.99 | $145,879.50 | View Details |
13 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.